Letter to Editor

Fusco, V., Bedogni, A., Addeo, A., Campisi, G. (2017). Definition and estimation of osteonecrosis of jaw (ONJ), and optimal duration of antiresorptive treatment in bone metastatic cancer patients: supplementary data from the denosumab extension study?. SUPPORTIVE CARE IN CANCER, 25(2), 345-349 [10.1007/s00520-016-3147-9].

Definition and estimation of osteonecrosis of jaw (ONJ), and optimal duration of antiresorptive treatment in bone metastatic cancer patients: supplementary data from the denosumab extension study?

CAMPISI, Giuseppina
2017-01-01

Abstract

Letter to Editor
2017
Fusco, V., Bedogni, A., Addeo, A., Campisi, G. (2017). Definition and estimation of osteonecrosis of jaw (ONJ), and optimal duration of antiresorptive treatment in bone metastatic cancer patients: supplementary data from the denosumab extension study?. SUPPORTIVE CARE IN CANCER, 25(2), 345-349 [10.1007/s00520-016-3147-9].
File in questo prodotto:
File Dimensione Formato  
Definition and estimation of osteonecrosis of jaw (ONJ), and optimal duration of antiresorptive treatment in bone metastatic cancer patients - supplementary data from the denosumab extension study.pdf

accesso aperto

Dimensione 286.32 kB
Formato Adobe PDF
286.32 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/225878
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 12
  • ???jsp.display-item.citation.isi??? 10
social impact